Get started
Author

Jake M. Pry

Observed names: J. M. Pry, J.M. Pry, Jake M. Pry, Jake M Pry, Jake Michael Pry, Jake Pry, Jesse “Jake” Pry, Pry J.M., Pry, Jake
ORCID: 0000-0001-6312-4420
Observed ORCID: 0000-0001-6312-4420
OpenAlex ID: A5048189489
Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting
2023 · Joy E Lawn, Joy E Lawn, et al. · The Lancet · 381
PDF
Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection — California, February–December 2021
2022 · Kristin L. Andrejko, Jake M. Pry, et al. · MMWR Morbidity and Mortality Weekly Report · 194
PDF
Human-Centered Design Lessons for Implementation Science: Improving the Implementation of a Patient-Centered Care Intervention
2019 · Laura K. Beres, Sandra Simbeza, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 117
Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California
2021 · Kristin L Andrejko, Jake Pry, et al. · Clinical Infectious Diseases · 46
PDF
Prevention of COVID-19 by mRNA-based vaccines within the general population of California
2021 · Kristin L. Andrejko, Jake Pry, et al. · medRxiv · 43
PDF
Cervical cancer screening outcomes in Zambia, 2010–19: a cohort study
2021 · Jake M Pry, Albert Manasyan, et al. · The Lancet Global Health · 37
PDF
Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity
2021 · Aaloke Mody, Izukanji Sikazwe, et al. · The Lancet HIV · 36
Patterns and Predictors of Incident Return to HIV Care Among Traced, Disengaged Patients in Zambia: Analysis of a Prospective Cohort
2020 · Laura K. Beres, Sheree Schwartz, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 34
Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia
2018 · Aaloke Mody, Izukanji Sikazwe, et al. · PLoS Medicine · 31
PDF
Waning of 2-Dose BNT162b2 and mRNA-1273 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Accounting for Depletion-of-Susceptibles Bias
2023 · Kristin L Andrejko, Jake M Pry, et al. · American Journal of Epidemiology · 28
PDF
Severe Acute Respiratory Syndrome Coronavirus 2 and Respiratory Virus Sentinel Surveillance, California, USA, May 10, 2020–June 12, 2021
2021 · Gail L. Sondermeyer Cooksey, Christina Morales, et al. · Emerging infectious diseases · 27
PDF
Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
2021 · Kristin L Andrejko, Jake Pry, et al. · Clinical Infectious Diseases · 26
PDF
Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: A registry-linkage study
2023 · Kristin L. Andrejko, Jennifer F. Myers, et al. · Vaccine · 24
Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia
2020 · Michael J. Vinikoor, Edford Sinkala, et al. · PLoS ONE · 22
PDF
Profiles of HIV Care Disruptions Among Adult Patients Lost to Follow-up in Zambia: A Latent Class Analysis
2020 · Aaloke Mody, Kombatende Sikombe, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 21
Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study
2020 · Andrew D. Kerkhoff, Kombatende Sikombe, et al. · PLoS Medicine · 21
PDF
Neonatal mortality risk of vulnerable newborns: A descriptive analysis of subnational, population‐based birth cohorts for 238 203 live births in low‐ and middle‐income settings from 2000 to 2017
2023 · Elizabeth A. Hazel, Daniel J. Erchick, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 20
PDF
Sexual and reproductive health services during outbreaks, epidemics, and pandemics in sub-Saharan Africa: a literature scoping review
2022 · Mwila Ng’andu, Aldina Mesic, et al. · Systematic Reviews · 20
PDF
A pilot case-control study using a one health approach to evaluate behavioral, environmental, and occupational risk factors for chronic kidney disease of unknown etiology in Sri Lanka
2021 · Jake M. Pry, Wendi Jackson, et al. · One Health Outlook · 20
PDF
Patient‐reported reasons for declining same‐day antiretroviral therapy initiation in routine HIV care settings in Lusaka, Zambia: results from a mixed‐effects regression analysis
2020 · Jake Pry, Jenala Chipungu, et al. · Journal of the International AIDS Society · 20
PDF
Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021–2022 influenza season
2022 · Kristin L. Andrejko, Jennifer F. Myers, et al. · Vaccine · 19
PDF
Longitudinal Care Cascade Outcomes Among People Eligible for Antiretroviral Therapy Who Are Newly Linking to Care in Zambia: A Multistate Analysis
2020 · Aaloke Mody, David V Glidden, et al. · Clinical Infectious Diseases · 19
PDF
Understanding patient transfers across multiple clinics in Zambia among HIV infected adults
2020 · Kombatende Sikombe, Aaloke Mody, et al. · PLoS ONE · 18
PDF
Pilot Implementation of a User-Driven, Web-Based Application Designed to Improve Sexual Health Knowledge and Communication Among Young Zambians: Mixed Methods Study
2022 · Anjali Sharma, Chanda Mwamba, et al. · Journal of Medical Internet Research · 17
PDF
Mitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before–after cohort study using mixed effects regression
2022 · Jake M Pry, Kombatende Sikombe, et al. · BMJ Global Health · 17
PDF
Works count: 73
Citation count: 1,462
H-index: 20
I10-index: 35
Year
Topic
Type